Adalta Secures A$1.28 Million In Rights Offer To Advance AD-214


(MENAFN- News Direct) AdAlta Ltd (ASX:1AD) managing director Dr Tim Oldham tells Proactive the company's rights offer has raised A$1.28 million before costs, with commitments in hand to achieve the balance of the A$3.15 million target. The proceeds will help fund the early return to the clinic for lead asset AD-214 as well as progress partnering discussions.



MENAFN25052023005728012573ID1106316669


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.